We are live on ! Find out more
ANAB icon

AnaptysBio
ANAB

116 hedge funds and large institutions have $441M invested in AnaptysBio in 2020 Q1 according to their latest regulatory filings, with 19 funds opening new positions, 43 increasing their positions, 37 reducing their positions, and 22 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more funds holding in top 10

Funds holding in top 10: 3 → 6 (+3)

16% more repeat investments, than reductions

Existing positions increased: 43 | Existing positions reduced: 37

10.29% more ownership

Funds ownership: 104.23% → 114.53% (+10%)

4% less capital invested

Capital invested by funds: $457M → $441M (-$16.1M)

4% less funds holding

Funds holding: 121 → 116 (-5)

14% less first-time investments, than exits

New positions opened: 19 | Existing positions closed: 22

31% less call options, than puts

Call options by funds: $2.44M | Put options by funds: $3.52M

Holders
116
Holders Change
-5
Holders Change %
-4.13%
% of All Funds
2.56%
Holding in Top 10
6
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+100%
% of All Funds
0.13%
New
19
Increased
43
Reduced
37
Closed
22
Calls
$2.44M
Puts
$3.52M
Net Calls
-$1.08M
Net Calls Change
+$2.56M

Top Buyers

Rank Fund Capital Flow
1
ACM
Aquilo Capital Management
California
+$21.8M
2
EC
EcoR1 Capital
California
+$16.2M
3
BI
BVF Inc
California
+$11.4M
4
CAM
Cormorant Asset Management
Massachusetts
+$11.3M
5
TCM
Tang Capital Management
California
+$6.78M

Top Sellers

Rank Fund Capital Flow
1
Federated Hermes
Federated Hermes
Pennsylvania
-$16.8M
2
Morgan Stanley
Morgan Stanley
New York
-$8.25M
3
PA
Perceptive Advisors
New York
-$7.58M
4
Millennium Management
Millennium Management
New York
-$6.11M
5
Goldman Sachs
Goldman Sachs
New York
-$2.95M
Name Holding Trade Value Shares
Change 		Change in
Stake
UBS Group
101
UBS Group
Switzerland
$12K -$8.23K -543 -39%
BBHC
102
Brown Brothers Harriman & Co
New York
$11K – – –
US Bancorp
103
US Bancorp
Minnesota
$9K -$3.55K -234 -27%
MAM
104
Meeder Asset Management
Ohio
$8K +$2.38K +157 +40%
QI
105
QS Investors
New York
$8K +$7.58K +500 New
S
106
SignatureFD
Georgia
$3K +$2.97K +196 New
PCM
107
Prelude Capital Management
New York
$2K -$45.1K -2,975 -96%
Royal Bank of Canada
108
Royal Bank of Canada
Ontario, Canada
$2K -$27K -1,782 -92%
Daiwa Securities Group
109
Daiwa Securities Group
Japan
$2K – – –
EW
110
Evoke Wealth
California
$1.79K – – –
Bank of Montreal
111
Bank of Montreal
Ontario, Canada
$1K -$45.5K -3,003 -98%
LC
112
Lindbrook Capital
California
$1K +$637 +42 New
TPCW
113
TD Private Client Wealth
New York
$382 +$258 +17 +170%
Norges Bank
114
Norges Bank
Norway
– -$2.46M -151,538 Closed
IC
115
Ikarian Capital
Texas
– -$2.32M -143,000 Closed
Rafferty Asset Management
116
Rafferty Asset Management
New York
– -$1.24M -76,304 Closed
Jane Street
117
Jane Street
New York
– -$596K -36,709 Closed
JG
118
Jefferies Group
New York
– -$488K -30,000 Closed
BFM
119
Boothbay Fund Management
New York
– -$484K -29,775 Closed
Point72 Asset Management
120
Point72 Asset Management
Connecticut
– -$421K -25,900 Closed
TI
121
Trexquant Investment
Connecticut
– -$327K -20,153 Closed
GP
122
Girard Partners
Pennsylvania
– -$243K -15,000 Closed
PC
123
PA Capital
Virginia
– -$236K -14,520 Closed
Allianz Asset Management
124
Allianz Asset Management
Germany
– -$221K -13,630 Closed
GTC
125
Ghost Tree Capital
New York
– -$187K -11,500 Closed
2 3 4
5
6

ANAB Hedge Fund Activity: Q1 2020 in Review

116 of the 4,539 institutional investors tracked by Wall St. Rank reported a position in AnaptysBio (ANAB) for Q1 2020, worth a combined $441M — down 3.5% from $457M a quarter earlier.

Sellers outnumbered buyers: 22 funds closed out of ANAB and 19 opened new positions — a net loss of 3 holders — while 37 trimmed existing stakes and 43 added.

The largest buyer was Aquilo Capital Management, opening a new position worth an estimated $21.8M. The largest seller was Federated Hermes, cutting an estimated $16.8M.

  • 116 institutional investors held AnaptysBio (ANAB) as of Q1 2020, down from 121 in Q4 2019.
  • Funds reported $441M of AnaptysBio stock for Q1 2020, down 3.5% quarter-over-quarter.
  • 19 funds opened new AnaptysBio positions in Q1 2020 and 22 closed out, a net change of -3 holders.
  • The largest AnaptysBio buyer in Q1 2020 was Aquilo Capital Management, an estimated $21.8M added.
  • The largest AnaptysBio seller in Q1 2020 was Federated Hermes, an estimated $16.8M sold.

Based on aggregated 13F filings for Q1 2020.